Financial Ratios

DOLPHIN LABORATORIES LTD.

NSE : NABSE : 524578ISIN CODE : INE840C01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE5.750 (0 %)
PREV CLOSE ( ) 5.75
OPEN PRICE ( ) 6.18
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )6.18 6.18
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Select year
ParticularsMar2002Mar2001Mar2000Mar1999
Operational & Financial Ratios
   Earnings Per Share (Rs)-8.75-14.34-13.56-61.90
   CEPS(Rs)-7.22-12.71-12.06-60.49
   DPS(Rs)0.000.000.000.00
   Book NAV/Share(Rs)2.1710.3326.9840.17
   Tax Rate(%)0.000.000.00-0.15
Margin Ratios
   Core EBITDA Margin(%)-18.20-33.92-38.12-128.70
   EBIT Margin(%)-17.94-33.45-27.55-124.16
   Pre Tax Margin(%)-26.47-40.17-32.90-134.16
   PAT Margin (%)-26.47-40.17-32.90-134.36
   Cash Profit Margin (%)-21.86-35.61-29.26-131.29
Performance Ratios
   ROA(%)-12.84-17.84-14.31-61.25
   ROE(%)-139.93-76.84-40.39-154.10
   ROCE(%)-17.39-28.84-22.32-100.95
   Asset Turnover(x)0.490.440.440.46
   Sales/Fixed Asset(x)0.740.800.941.05
   Working Capital/Sales(x)36.746.143.784.82
Efficiency Ratios
   Fixed Capital/Sales(x)1.351.241.070.96
   Receivable days73.4180.7077.3465.85
   Inventory Days134.74146.77135.44122.62
   Payable days279.92373.85440.35431.57
Valuation Parameters
   PER(x)0.000.000.000.00
   PCE(x)-0.550.00-0.81-0.18
   Price/Book(x)1.850.000.360.27
   Yield(%)0.000.000.00
   EV/Net Sales(x)0.961.030.710.49
   EV/Core EBITDA(x)-7.05-3.31-2.56-0.33
   EV/EBIT(x)-5.24-2.86-2.23-0.33
   EV/CE(x)0.490.470.290.18
   M Cap / Sales0.120.000.270.29
Growth Ratio
   Net Sales Growth(%)-2.30-7.56-6.010.00
   Core EBITDA Growth(%)57.29-4.6382.330.00
   EBIT Growth(%)50.34-5.1180.140.00
   PAT Growth(%)38.99-5.7178.090.00
   EPS Growth(%)38.99-5.7178.090.00
Financial Stability Ratios
   Total Debt/Equity(x)13.082.650.670.41
   Current Ratio(x)1.041.251.321.27
   Quick Ratio(x)0.550.660.880.83
   Interest Cover(x)-2.10-4.98-5.15-12.41
   Total Debt/Mcap(x)7.081.861.50

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.